These results suggest that ARHGAP30 may act downstream of KIAA1429 and play a significant role in the tumor‐suppressive pathways affected by KIAA1429 in LUAD, offering potential insights into the molecular interplay that could be leveraged for therapeutic strategies in LUAD. The gene discussed is VIRMA; the disease is neoplasm.